Clinical Trials Browser

Phase 2/3 × Fatigue × Thoracic × Clear all

NCT00518869 2025-06-04

Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue

Phase 2/3 Terminated

Carcinoma, Non-Small-Cell Lung, Fatigue